Showing posts with label a selective methionine aminopeptidase 2 inhibitor (MetAP2). Show all posts
Showing posts with label a selective methionine aminopeptidase 2 inhibitor (MetAP2). Show all posts
Sunday, August 19, 2012

Zafgen announces new data from two Phase 1 studies of beloranib on obesity

›
Zafgen announces new data from two Phase 1 studies of beloranib on obesity : Zafgen, Inc., the world's first biopharmaceutical company...